Works matching IS 00411132 AND DT 2024 AND VI 64 AND IP 2


Results: 30
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes.

    Published in:
    Transfusion, 2024, v. 64, n. 2, p. 236, doi. 10.1111/trf.17706
    By:
    • Mo, Allison;
    • Wood, Erica;
    • Shortt, Jake;
    • Charlton, Andrew;
    • Evers, Dorothea;
    • Hoeks, Marlijn;
    • Pritchard, Elizabeth;
    • Daly, James;
    • Hodgson, Carol;
    • Opat, Stephen;
    • Bowen, David;
    • Reynolds, John;
    • Thi Phung Thao, Le;
    • Stanworth, Simon J.;
    • McQuilten, Zoe
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18

    D−− phenotype caused by a novel RHCE null allele.

    Published in:
    Transfusion, 2024, v. 64, n. 2, p. E3, doi. 10.1111/trf.17698
    By:
    • Principi, Cintia;
    • Trucco Boggione, Carolina;
    • Ensinck, Alejandra;
    • Posner, Victoria;
    • Luján Brajovich, Melina;
    • Stettler, Silvina;
    • Mattaloni, Stella;
    • Biondi, Claudia;
    • Cotorruelo, Carlos
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Cover.

    Published in:
    Transfusion, 2024, v. 64, n. 2, p. C1, doi. 10.1111/trf.17423
    Publication type:
    Article